Month

SpyGlass Pharma Unveils Compelling 1-Year Data of Its Innovative Drug Delivery Platform Implanted During Routine Cataract Surgery in Eyes with Glaucoma

Retrieved on: 
Tuesday, April 2, 2024
IOP, Bimatoprost, Glaucoma, Ocular hypertension, Pressure, IOL, ASCRS, Patient, Tissue, Cataract, Month, Spyglass, Visual acuity, Society, Safety, IOPS, Therapy, FDA, Intraocular pressure, Annual general meeting, Pharmaceutical industry

ALISO VIEJO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held ophthalmic biotechnology company, announced today 1-year follow up data from a first-in-human study of 23 patients with glaucoma or ocular hypertension implanted with SpyGlass’ Intraocular Lens (IOL) based Drug Delivery Platform with bimatoprost at the time of cataract surgery. These data will be highlighted in a poster presentation during the American Society of Cataract and Refractive Surgeons (ASCRS) Annual Meeting, held from April 5-8 in Boston.

Key Points: 
  • ALISO VIEJO, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a privately-held ophthalmic biotechnology company, announced today 1-year follow up data from a first-in-human study of 23 patients with glaucoma or ocular hypertension implanted with SpyGlass’ Intraocular Lens (IOL) based Drug Delivery Platform with bimatoprost at the time of cataract surgery.
  • The SpyGlass platform was well tolerated and there were no adverse events related to the product.
  • These data highlight the substantial potential of the SpyGlass Drug Delivery Platform to be a game changer for patients and all cataract surgeons.”
    “SpyGlass technology has the potential to change the paradigm and improve care for glaucoma patients undergoing routine cataract surgery,” said Patrick Mooney, CEO, SpyGlass PharmaTM.
  • The compelling clinical data released this week suggest we are on track to bringing our innovative platform to patients.”
    The SpyGlass Drug Delivery Platform with bimatoprost is designed to deliver 3 years of bimatoprost to targeted tissues.

Three-Year Follow-up Data in BCG-Unresponsive NMIBC Show Durable Response to Treatment with ADSTILADRIN® (nadofaragene firadenovec-vncg) in Two Patient Cohorts

Retrieved on: 
Monday, April 8, 2024
Biotechnology, Pharmaceutical, Managed Care, Oncology, General Health, Health, FDA, Clinical Trials, NMIBC, BCG, Toxicity, HG, Physician, Congress, Nadofaragene firadenovec, Survival, PD, Cystectomy, Ferring Pharmaceuticals, Patient, Aes, EAU, MD Anderson Cancer Center, University, Month, Carcinoma in situ, Safety, Division, Probability, CIS, Food, Pharmaceutical industry

“Intravesical gene therapy represents an important innovative treatment option for these patients.

Key Points: 
  • “Intravesical gene therapy represents an important innovative treatment option for these patients.
  • The efficacy analysis included 103 and 48 patients in the CIS and PD cohorts, respectively, who met the protocol definition of BCG-unresponsive NMIBC.
  • In total, 12.1% (13/107) and 20.0% (10/50) of patients in the CIS and PD cohorts, respectively, received ADSTILADRIN at three years.
  • In the CIS cohort, about 53% achieved a complete response (CR) at Month 3 in the primary analysis.

Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension

Retrieved on: 
Sunday, April 7, 2024
Research, FDA, Clinical Trials, Cardiology, Biotechnology, Managed Care, Health, Pharmaceutical, Science, Blood pressure, Medication, Indapamide, Risk, Patient, Month, SBP, ABPM, American College, Olmesartan, Injection, Safety, RNA interference, Therapy, AGT, ACC, Amlodipine, Cardiomyopathy, Hypertension, Pharmaceutical industry

Zilebesiran is an investigational RNAi therapeutic targeting liver-expressed angiotensinogen (AGT) in development for the treatment of hypertension with the potential for biannual dosing.

Key Points: 
  • Zilebesiran is an investigational RNAi therapeutic targeting liver-expressed angiotensinogen (AGT) in development for the treatment of hypertension with the potential for biannual dosing.
  • The results were presented today as a late-breaking clinical trial at the 2024 American College of Cardiology (ACC) Annual Scientific Session.
  • The Company previously announced positive topline results from the KARDIA-2 study in March 2024.
  • “Although many effective oral treatments are available, a large proportion of patients with hypertension are not managed to guideline-recommended targets.

Home Hardware and the Toronto Blue Jays™ announce the BeautiTone Balcony, a one-of-a-kind viewing area at Rogers Centre

Retrieved on: 
Monday, April 8, 2024
Month, Toronto Blue Jays, Rogers Centre, Home Hardware, Nightclub

ST. JACOBS, ON, April 8, 2024 /CNW/ - Home Hardware Stores Limited , Canada's largest Dealer-owned home improvement retailer, and the Toronto Blue Jays™ announce the BeautiTone Balcony at Rogers Centre.

Key Points: 
  • ST. JACOBS, ON, April 8, 2024 /CNW/ - Home Hardware Stores Limited , Canada's largest Dealer-owned home improvement retailer, and the Toronto Blue Jays™ announce the BeautiTone Balcony at Rogers Centre.
  • "As a partner to the Toronto Blue Jays since 2005, Home Hardware is delighted to mark its 60th Anniversary and the 2024 Home Opener with the announcement of the BeautiTone Balcony," said Laura Baker, Chief Marketing Officer, Home Hardware Stores Limited.
  • BeautiTone, Home Hardware's private label paint product, is the number one Canadian-made and owned retail paint brand and the Official Paint of the Toronto Blue Jays™.
  • In 2018, BeautiTone unveiled the Toronto Blue Jays Colour Collection , which pulls from the team colours and stadium features.

BE OPEN Art launches the second regional competition of 2024 to support emerging artists of Middle East

Retrieved on: 
Monday, April 8, 2024
Month, Social consciousness, Artist, Creativity, Region

LONDON, April 8, 2024 /PRNewswire/ -- BE OPEN Art , an online gallery set up by Elena Baturina's humanitarian think-tank BE OPEN, continues to run BE OPEN Regional Art, the regional competition for emerging artists aimed to support those whose art best represents their regional, cultural and ethnic identities.

Key Points: 
  • LONDON, April 8, 2024 /PRNewswire/ -- BE OPEN Art , an online gallery set up by Elena Baturina's humanitarian think-tank BE OPEN, continues to run BE OPEN Regional Art, the regional competition for emerging artists aimed to support those whose art best represents their regional, cultural and ethnic identities.
  • Throughout 2024, BE OPEN expert community will continue selecting those artists who best represent the artistic tradition of a certain region to feature in the BE OPEN Art gallery and offer them greater visibility.
  • The second stage of the second year of the programme run will cover the countries of Middle East: Bahrain, Iran, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, and Yemen.
  • Later in 2024, BE OPEN Regional Art will travel to Central America and Southern Africa.

BE OPEN Art launches the second regional competition of 2024 to support emerging artists of Middle East

Retrieved on: 
Monday, April 8, 2024
Month, Social consciousness, Artist, Creativity, Region

LONDON, April 8, 2024 /PRNewswire/ -- BE OPEN Art , an online gallery set up by Elena Baturina's humanitarian think-tank BE OPEN, continues to run BE OPEN Regional Art, the regional competition for emerging artists aimed to support those whose art best represents their regional, cultural and ethnic identities.

Key Points: 
  • LONDON, April 8, 2024 /PRNewswire/ -- BE OPEN Art , an online gallery set up by Elena Baturina's humanitarian think-tank BE OPEN, continues to run BE OPEN Regional Art, the regional competition for emerging artists aimed to support those whose art best represents their regional, cultural and ethnic identities.
  • Throughout 2024, BE OPEN expert community will continue selecting those artists who best represent the artistic tradition of a certain region to feature in the BE OPEN Art gallery and offer them greater visibility.
  • The second stage of the second year of the programme run will cover the countries of Middle East: Bahrain, Iran, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, and Yemen.
  • Later in 2024, BE OPEN Regional Art will travel to Central America and Southern Africa.

Jersey Mike’s raises over 1.8 million to support The Valerie Fund

Retrieved on: 
Thursday, April 4, 2024
Men, Restaurant, Bar, Philanthropy, Oncology, Consumer, Food, Beverage, Fund Raising, Foundation, Parenting, Retail, Children, Women, Health, Chairperson, Patient, Cancer, Month, Life, Senior, Organic, Multimedia

The Valerie Fund joined forces with 132 Jersey Mike’s Subs in New Jersey and New York for the 14th Annual March “ Month of Giving ” campaign to support local charities.

Key Points: 
  • The Valerie Fund joined forces with 132 Jersey Mike’s Subs in New Jersey and New York for the 14th Annual March “ Month of Giving ” campaign to support local charities.
  • During the month of March, customers were invited to donate to The Valerie Fund at participating Jersey Mike’s restaurants.
  • Jersey Mike’s Month of Giving raised over $1.8 million for The Valerie Fund, including $500,000 that Jersey Mike’s Founder and CEO Peter Cancro announced on Day of Giving the company would donate to the nonprofit.
  • Neil Yaris, Board Chair said, “On behalf of the Board of the Valerie Fund, I would like to thank the entire Jersey Mike’s team.

Cathy Nguyen Named Provider of the Month at Relief Mental Health in Chicago

Retrieved on: 
Tuesday, April 2, 2024
Men, Research, General Health, LGBTQ+, Pharmaceutical, Consumer, Mental Health, Science, Neurology, Biotechnology, Women, Seniors, Health, Depression, Mental health, Brain, MDD, Empathy, Patient, Transcranial magnetic stimulation, TMS, Bipolar disorder, Anxiety, OCD, Cathy, Month, DSM-IV codes, Provider, MSN, TRD, Suicidal ideation, Field line, Esketamine, FDA, Nursing

Relief Mental Health , a leading outpatient provider of transcranial magnetic stimulation (TMS), psychedelic therapy, psychiatric medication management, and talk therapy, is thrilled to announce Psychiatric Nurse Practitioner Cathy Nguyen, MSN APRN PMHNP-BC as its esteemed Provider of the Month.

Key Points: 
  • Relief Mental Health , a leading outpatient provider of transcranial magnetic stimulation (TMS), psychedelic therapy, psychiatric medication management, and talk therapy, is thrilled to announce Psychiatric Nurse Practitioner Cathy Nguyen, MSN APRN PMHNP-BC as its esteemed Provider of the Month.
  • Nguyen has exhibited exceptional dedication and expertise in providing innovative mental health care to the community at Relief’s West Loop clinic in Chicago.
  • Susan Mueller, CEO of Relief Mental Health, expressed her admiration for Nguyen’s commitment to the organization’s core values.
  • To make an appointment with Nguyen or for more information about the innovative services offered at Relief Mental Health, call 855.205.4764, email [email protected] or visit reliefmh.com .

IHOP Brings Viral PEPSI® Maple Syrup Cola to Restaurants Nationwide, Among Assortment of Menu Innovations This Spring

Retrieved on: 
Monday, April 1, 2024
Retail, Restaurant, Bar, Food, Beverage, 2D, Taste, Lettuce, Partnership, Buttermilk, Nintendo, Month, Xbox One, IHOP, Breakfast, Pecan, Float, Cheese, Hedgehog, Sonic the Hedgehog, Sonic, Lunch, Multimedia, Fast food

Today, IHOP® announced it is bringing more smiles to more plates this spring with innovative new menu offerings, including the reintroduction of Pepsi® Maple Syrup Cola, exclusively in participating restaurants nationwide.

Key Points: 
  • Today, IHOP® announced it is bringing more smiles to more plates this spring with innovative new menu offerings, including the reintroduction of Pepsi® Maple Syrup Cola, exclusively in participating restaurants nationwide.
  • Now, IHOP and Pepsi® are bringing the indulgent taste of Pepsi® Maple Syrup Cola to the masses; starting April 1, the limited-time only flavor will be available in participating IHOP restaurants nationwide!
  • Pepsi® Maple Syrup Cola and Float: A perfect blend of maple syrup-flavored indulgence with the crisp, refreshing caramel notes of Pepsi®.
  • For more information on IHOP’s latest menu innovations or to find the nearest restaurant, please visit IHOP.com .

Get Your Faves Faster: Baskin-Robbins Rolls Out Mobile Ordering Nationwide

Retrieved on: 
Monday, March 18, 2024
Restaurant, Bar, Specialty, Technology, Apps, Applications, Food, Beverage, Online Retail, Mobile, Wireless, Retail, Taste, Month, Ice cream, Easter, App Store (iOS/iPadOS), Google Play, Ice, Multimedia, Frosting on the Beater, Online shopping

Baskin-Robbins® guests nationwide can now order flavorful ice cream scoops, cool beverages and yummy sundaes for pick up ahead of time with the new updates to the BR App .

Key Points: 
  • Baskin-Robbins® guests nationwide can now order flavorful ice cream scoops, cool beverages and yummy sundaes for pick up ahead of time with the new updates to the BR App .
  • Baskin-Robbins fans can download the BR App in the Google Play or App Store.
  • Guests can sweeten their celebration by pre-ordering these customizable ice cream cakes in the BR App or online .
  • To learn more about Baskin-Robbins’ app, premium ice cream flavors and frozen desserts, visit www.BaskinRobbins.com or follow along on Instagram , TikTok , Twitter and Facebook .